Quality Systems Approach Is Key To Transforming FDA – Crawford
This article was originally published in The Rose Sheet
Executive Summary
Capitalizing on information technology advances and regulatory process innovations are key factors in creating new vision for FDA, commissioner nominee Lester Crawford, DVM/PhD, said during a March 17 Senate Health Committee hearing on his nomination